Laboratory Corp. of America Holdings Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

Date: December 1, 2016
Pages: 50
Price:
US$ 499.00
Laboratory Corp. of America Holdings Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Publisher: BAC Reports
Report type: Strategic Report
Delivery: E-mail Delivery - PDF (on default),
Hard Copy Mail Delivery (+US$ 190.00)
ID: LB85013FBF0BEN
Leaflet:

Download PDF Leaflet

Laboratory Corp. of America Holdings Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Laboratory Corp. of America Holdings Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be made between Laboratory Corp. of America Holdings and its competitors. This provides our Clients with a clear understanding of Laboratory Corp. of America Holdings position in the Healthcare Industry.

  • The report contains detailed information about Laboratory Corp. of America Holdings that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
  • Another part of the report is a SWOT-analysis carried out for Laboratory Corp. of America Holdings. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
  • The Laboratory Corp. of America Holdings financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
  • In the part that describes Laboratory Corp. of America Holdings competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
  • Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Laboratory Corp. of America Holdings business.

About Laboratory Corp. of America Holdings

Laboratory Corporation of America Holdings is an independent clinical laboratory company in the United States. The company has a national network of 38 primary laboratories and approximately 1,500 patient service centers along with a network of branches and STAT laboratories (which are laboratories that have the ability to perform certain routine tests quickly and report the results to the physician immediately).

The company, through its national network of laboratories, offers a range of clinical laboratory tests that are used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease. In addition, the company has developed specialty testing operations, such as oncology testing, HIV genotyping and phenotyping, diagnostic genetics, and clinical trials.

The company processes tests on approximately 440,000 patient specimens daily and provides clinical laboratory testing services to clients in the 50 states, the District of Columbia, Puerto Rico, Belgium, and three provinces in Canada. Its clients include physicians, hospitals, managed care organizations, governmental agencies, employers, pharmaceutical companies, and other independent clinical laboratories that do not have the breadth of its testing capabilities.

Laboratory Testing Operations and Services

The company has a network of primary testing laboratories, specialty testing laboratories, branches, patient service centers and STAT laboratories. The patient service center collects the specimens as requested by the physician. Patient specimens are typically delivered to the Company accompanied by a test request form (electronic or hard copy). These forms, which are completed by the client or transcribed by a company patient service technician from a client order, indicate the tests to be performed and provide the necessary billing information.

Testing Services

Routine Testing

The company offers a range of clinical laboratory tests and procedures. These are frequently used in general patient care by physicians to establish or support a diagnosis, to monitor treatment or medication, or to search for an otherwise undiagnosed condition. The tests include blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, HIV tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. These routine procedures are most often used by physicians in their outpatient office practices. Physicians may elect to send such procedures to an independent laboratory or they may choose to establish their own laboratory to perform some of the tests.

Specialty Testing

The company’s subsidiary, National Genetics Institute, Inc. (NGI), engages in the development of PCR assays for Hepatitis C (HCV), and its Viro-Med Laboratories, Inc. subsidiary offers molecular microbial testing using real time PCR platforms. DIANON Systems, Inc. engages in anatomic pathology testing and the U.S. LABS engages in anatomic pathology and oncology testing services.

The company’s subsidiary, Esoterix, is a provider of specialty reference testing and Litholink Corporation (Litholink) is a kidney stone analysis laboratory known for its stone management program. In August 2009, the company acquired Monogram in HIV resistance testing, which has developed new technologies in oncology such as the measurement of proteins involved in cancer development and/or progression. The following are specialty testing operations in which the company offers testing and related services:

Infectious Disease: The company provides HIV testing services, including viral load measurements, genotyping and phenotyping and host genetic factors (HLAB5701) that are important tools in managing and treating HIV infections. The addition of the Monogram resistance tests, PhenoSense, PhenoSenseGT and Trofile, complement the existing HIV GenoSure assay and provide a portfolio of HIV resistance testing services. The company also provides testing services for HCV infections, including both viral load determinations and strain genotyping at CMBP, NGI and Viro-Med.

Diagnostic Genetics: The company offers cytogenetic, molec


The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get all the most recent data available for the same price. Please note that preparation of additional types of analyses requires extra time.

RESEARCH METHODOLOGY

DISCLAIMER

1. LABORATORY CORP. OF AMERICA HOLDINGS COMPANY PROFILE

1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History

2. LABORATORY CORP. OF AMERICA HOLDINGS BUSINESS OVERVIEW

2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units

3. LABORATORY CORP. OF AMERICA HOLDINGS SWOT ANALYSIS

3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats

4. LABORATORY CORP. OF AMERICA HOLDINGS FINANCIAL ANALYSIS

4.1. Financial Statements
  4.1.1. Income Statement
  4.1.2. Balance Sheet
  4.1.3. Cash Flow
4.2. Financial Ratios
  4.2.1. Profitability
  4.2.2. Margin Analysis
  4.2.3. Asset Turnover
  4.2.4. Credit Ratios
  4.2.5. Long-Term Solvency
  4.2.6. Growth Over Prior Year
  4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot

5. LABORATORY CORP. OF AMERICA HOLDINGS COMPETITORS AND INDUSTRY ANALYSIS

5.1. Laboratory Corp. of America Holdings Direct Competitors
5.2. Comparison of Laboratory Corp. of America Holdings and Direct Competitors Financial Ratios
5.3. Comparison of Laboratory Corp. of America Holdings and Direct Competitors Stock Charts
5.4. Laboratory Corp. of America Holdings Industry Analysis
  5.4.1. Healthcare Services Industry Snapshot
  5.4.2. Laboratory Corp. of America Holdings Industry Position Analysis

6. LABORATORY CORP. OF AMERICA HOLDINGS NEWS & EVENTS

6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events

7. LABORATORY CORP. OF AMERICA HOLDINGS EXPERTS REVIEW1

7.1. Experts Opinion
7.2. Experts Estimates

8. LABORATORY CORP. OF AMERICA HOLDINGS ENHANCED SWOT ANALYSIS2

9. UNITED STATES PESTEL ANALYSIS2

9.1. Political Factors
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors

10. LABORATORY CORP. OF AMERICA HOLDINGS IFE, EFE, IE MATRICES2

10.1. Internal Factor Evaluation Matrix
10.2. External Factor Evaluation Matrix
10.3. Internal External Matrix

11. LABORATORY CORP. OF AMERICA HOLDINGS PORTER FIVE FORCES ANALYSIS2

12. LABORATORY CORP. OF AMERICA HOLDINGS VRIO ANALYSIS2


APPENDIX: RATIO DEFINITIONS


LIST OF TABLES

Laboratory Corp. of America Holdings Key Facts
Profitability
Management Effectiveness
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Laboratory Corp. of America Holdings Key Executives
Key Executives Biographies1
Key Executives Compensations1
Laboratory Corp. of America Holdings Major Shareholders
Laboratory Corp. of America Holdings History
Laboratory Corp. of America Holdings Products
Revenues by Segment
Revenues by Region
Laboratory Corp. of America Holdings Offices and Representations
Laboratory Corp. of America Holdings SWOT Analysis
Yearly Income Statement Including Trends
Income Statement Latest 4 Quarters Including Trends
Yearly Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Yearly Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
Laboratory Corp. of America Holdings Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Credit Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Laboratory Corp. of America Holdings Capital Market Snapshot
Laboratory Corp. of America Holdings Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Healthcare Services Industry Statistics
Laboratory Corp. of America Holdings Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Laboratory Corp. of America Holdings Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Historical Surprises1
Revenue Estimates Trend1
Earnings Estimates Trend1
Revenue Revisions1

LIST OF FIGURES

Laboratory Corp. of America Holdings Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Laboratory Corp. of America Holdings 1-year Stock Charts
Laboratory Corp. of America Holdings 5-year Stock Charts
Laboratory Corp. of America Holdings vs. Main Indexes 1-year Stock Chart
Laboratory Corp. of America Holdings vs. Direct Competitors 1-year Stock Charts
Laboratory Corp. of America Holdings Article Density Chart

1 – Data availability depends on company’s security policy.
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for publicly traded companies.

Enhanced SWOT Analysis

Enhanced SWOT is a 3×3 grid that arranges strengths, weaknesses, opportunities and threats into one scheme:

  • How to use the strengths to take advantage of the opportunities?
  • How to use the strengths to reduce likelihood and impact of the threats?
  • How to overcome the weaknesses that obstruct taking advantage of the opportunities?
  • How to overcome the weaknesses that can make the threats a reality?

Upon answering these questions a company can develop a project plan to improve its business performance.


PESTEL Analysis

PESTEL (also termed as PESTLE) is an ideal tool to strategically analyze what influence different outside factors – political, economic, sociocultural, technological, environmental and legal – exert on a business to later chart its long term targets.

Being part of the external analysis when carrying out a strategic assessment or performing a market study, PESTEL gives an overview of diverse macro-environmental factors that any company should thoughtfully consider. By perceiving these outside environments, businesses can maximally benefit from the opportunities while minimizing the threats to the organization.

Key Factors Examined by PESTEL Analysis:

  • Political – What opportunities and pressures are brought by political bodies and what is the degree of public regulations’ impact on the business?
  • Economic – What economic policies, trends and structures are expected to affect the organization, what is this influence’s degree?
  • Sociological – What cultural and societal aspects will work upon the demand for the business’s products and operations?
  • Technological – What impact do the technological aspects, innovations, incentives and barriers have on the organization?
  • Environmental – What environmental and ecological facets, both locally and farther afield, are likely to predetermine the business?
  • Legal – What laws and legislation will exert influence on the style the business is carried out?

IFE, EFE, IE Matrices

The Internal Factor Evaluation matrix (IFE matrix) is a strategic management tool helping audit or evaluate major weaknesses and strengths in a business’s functional areas. In addition, IFE matrix serves as a basis for identifying and assessing relationships amongst those areas. The IFE matrix is utilised in strategy formulation.

The External Factor Evaluation matrix (EFE matrix) is a tool of strategic management that is typically utilised to assess current market conditions. It is an ideal instrument for visualising and prioritising the threats and opportunities a firm is facing.

The essential difference between the above mentioned matrices lies in the type of factors incorporated in the model; whilst the latter is engaged in internal factors, the former deals exceptionally with external factors – those exposed to social, political, economic, legal, etc. external forces.

Being a continuation of the EFE matrix and IFE matrix models, the Internal External matrix (IE matrix) rests upon an investigation of external and internal business factors integrated into one suggestive model.


Porter Five Forces Analysis

The Porter’s five forces analysis studies the industry of operation and helps the company find new sources of competitive advantage. The analysis surveys an industry through five major questions:

  1. What composes a threat of substitute products and services?
  2. Is there a threat of new competitors entering the market?
  3. What is the intensity of competitive rivalry?
  4. How big is the bargaining power of buyers?
  5. How significant is the bargaining power of suppliers?

VRIO Analysis

VRIO stands for Value, Rarity, Imitability, Organization. This analysis helps to evaluate all company’s resources and capabilities and bring them together into one aggregate table that includes:

  • Tangible resources
    • Financial
    • Physical
    • Technological
    • Organizational
  • Intangible resources
    • Human
    • Innovation and Creativity
    • Reputation
  • Organizational capabilities

The result of the analysis gives a clear picture of company’s competitive and economic implications, answering the questions if the resources mentioned above are:

  • Valuable?
  • Rare?
  • Costly to imitate?
  • Organized properly?
Skip to top


Ask Your Question

Laboratory Corp. of America Holdings Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: